FindTrial
Sign In

A phase I/II clinical trial of carbon-ion radiotherapy in 12 fractions for prostate cancer

A phase I/II clinical trial of carbon-ion radiotherapy in 12 fractions for prostate cancer - 12-fractionation carbon-ion RT for prostate cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003838
Enrollment
45
Registered
2010-07-01
Start date
2010-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

carbon-ion radiotherapy in 12 fractions

Sponsors

National Institute of Radiological Sciences, Network congress of charged particle therapy
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)pathologically confirmed prostate cancer 2)T1b,T1c,T2a,T2b,T2c,T3a, or T3b, and M0 in UICC TNM classification in 2009 3)clinically N0 (by imaging) or pathologically N0 or N1 (in 1992 UICC, solitary positive node less than 2cm in diameter) 4)signed consent form

Exclusion criteria

Exclusion criteria: 1)previous radiation therapy for pelvis 2)expected survival period < 6 months 3)Performance status worse than 2 4)previous treatment other than hormonal therapy for prostate cancer 5)concurrent other malignancy 6)active infection in pelvis 7)not inclusive because of other serious medical or psychological problem

Design outcomes

Primary

MeasureTime frame
incidence of late radiation toxicity—

Secondary

MeasureTime frame
relapse-free survival rate, overall survival rate, cause-specific survival rate, quality of life assessment—

Countries

Japan

Contacts

Public ContactHiroshi Tsuji

National Institute of Radiological Sciences Research center for charged particle therapy

h_tsuji@nirs.go.jp043-206-3350

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026